Ajanta Pharma Ltd operates six finished dose manufacturing facilities that manufacture high quality generics across a broad array of dosage forms, including tablets, capsules, ointments, injectables and powders.
Our flagship finished oral solid dosage facility in Aurangabad, India has been inspected and approved by the US Food and Drug Administration (FDA), World Health Organization pre-qualification for two of its products, and various other regulatory agencies throughout the world. Our robust process development and proprietary technology across various product platforms ensures Ajanta is producing high quality products efficiently.
A new oral solid dosage facility in Dahej, employing the latest, state of the art equipment and procedures has been commissioned which is taking validation & regulatory submission batches. A second site to support growth in India & emerging markets is operationalized in January 2017.